Advertisement
Advertisement

IMAB

IMAB logo

I-MAB - ADR

0.85
USD
+0.01
+0.79%
Apr 17, 15:58 UTC -4
Closed
exchange

After-Market

0.85

0.00
-0.12%

I-MAB - ADR Profile

About

I-Mab is a clinical stage biopharmaceutical company. It engages in discovery, development and commercialization of biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab is based in SHANGHAI, China.

Info & Links

CEO

Raj Kannan

Headquarters

SUITE 400, 2440 RESEARCH BLVD
ROCKVILLE, MD 20850, UNITED STATES

Sector

Medical

Auditor

PricewaterhouseCoopers Zhong Tian LLP

Share holders

--

Employees

220

I-MAB - ADR Statistics

Valuation Measures

Market Capitalization2

69.03M

Enterprise Value

768.42K

Enterprise Value/EBITDA(ttm)

-0.03

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.36

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-12.28%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-27.42M

Net Income Available to Common(ttm)

4.64M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.07

52-Week Change

-53.15%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

81.50M

Dividend Yield

0.00%

Float4

63.49M

% Held by Insiders

22.10%

% Held by Institutions

38.38%

Balance Sheet

Total Cash(mrq)

173.40M

Total Cash Per Share(mrq)

2.13

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

15.99%

Quick Ratio(mrq)

15.99%

Book Value Per Share(mrq)

2.67

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement